Series A - BioIntelliSense

Series A - BioIntelliSense

Investment Firm

Overview

BioIntelliSense, a continuous health monitoring and clinical intelligence company with medical-grade wearable devices and Data-as-a-Service.

Announced Date

Jul 09, 2019

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Fresenius Medical Care North America

Fresenius Medical Care North America

No designation

Participant Investors

3

Investor Name
Participant InvestorFresenius Medical Care North America
Participant InvestorFresenius Medical Care
Participant InvestorJonathan Weiner

Round Details and Background

BioIntelliSense raised $24997665 on 2019-07-09 in Series A

BioIntelliSense, a continuous health monitoring and clinical intelligence company with medical-grade wearable devices and Data-as-a-Service.

Company Funding History

4

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jul 09, 2019
Series A - BioIntelliSense
3-25.0M
Sep 10, 2020
Venture Round - BioIntelliSense
-12.0M
Jul 28, 2021
Series B - BioIntelliSense
7-45.0M
Dec 22, 2020
Grant - BioIntelliSense
1-2.8M

Recent Activity

There is no recent news or activity for this profile.